Navigation Links
Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
Date:8/25/2009

vessels (veins), especially in your leg (deep venous thrombosis or DVT). Pieces of a blood clot may travel to the lungs and block the blood circulation in the lungs (pulmonary embolus).

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statements

This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
2. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
3. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
6. Medarex to Receive Milestone Payment from Amgen
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
10. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
11. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... , Sept. 14, 2014 /PRNewswire-iReach/ -- "Hematoma Global Clinical ... clinical trial scenario. This report provides elemental information and ... includes an overview of the trial numbers and their ... across the globe. The databook offers a preliminary coverage ... prominence of the sponsors and also provides briefing pertaining ...
(Date:9/13/2014)... 13, 2014  Edwards Lifesciences Corporation (NYSE: ... science of heart valves and hemodynamic monitoring, today ... inoperable patients treated in The PARTNER Trial, the ... valve replacement (TAVR) in patients deemed too sick ... part of the late-breaking clinical trials session at ...
(Date:9/12/2014)... DUBLIN, Ireland , September ... ,Research and Markets ( ... addition of the  "Global Pipeline ... Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, ... - Trends and Forecast to ...
Breaking Medicine Technology:Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 2Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 3Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 4Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 5Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data 2Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020 2Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020 3
... Mass., Nov. 6 Boston Scientific Corporation (NYSE: ... agreement in principle with the U.S. Department of Justice ... subsidiary in 2005. The alleged conduct and product ... Guidant. , Boston Scientific had previously disclosed an investigation ...
... 6 With his proposed health care reform plan, President ... drug costs by 50 percent for Medicare patients who fall ... "donut hole." Plan advocates rave about the potential cost-cutting and ... some of the most powerful lobbyists want a revised program ...
Cached Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3
(Date:9/14/2014)... 2014 DePuy ASR hip lawsuits ... courts throughout the U.S., Bernstein Liebhard LLP reports. ... Superior Court, defendants in claims pending in California’s ... proceeding to deny a request by certain plaintiffs ... Superior Court. Plaintiffs seeking re-transfer originally filed their ...
(Date:9/14/2014)... New York, NY (PRWEB) September 14, 2014 ... to be filed in New Jersey, where two separate ... Bernstein Liebhard LLP reports. , According to Case ... now been filed over devices marketed by C.R. Bard ... consolidated proceeding involving cases against C.R. Bard, a total ...
(Date:9/14/2014)... September 14, 2014 A new DePuy Pinnacle ... LLC on behalf of a Franklin County, Ohio man ... implant. The metal-on-metal hip lawsuit filed against Johnson & ... Ohio man was 40 years old when the Pinnacle Hip ... 3:14-cv-02428-K) According to the hip implant lawsuit , ...
(Date:9/14/2014)... 2014 UWDress.com, is an internationally well-known ... recently announced its new range of cocktail dresses ... more benefits to worldwide ladies, the company is also ... wedding outfits, blue evening gowns, black formal gowns and ... percent off. , The company’s senior spokesman says, ...
(Date:9/13/2014)... 2014 “I had made a personal ... in major cities, is quite contaminated and polluted,” said ... thought we deserved a healthier alternative.” In an effort ... , THE OXYGENIZER prevents pollutants and contaminated air from ... so, it provides added peace of mind and may ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 3Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 4Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 2Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 3Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 5Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:Personal Air Filtering Device Invented by InventHelp Clients (TOR-9166) 2
... is being published showing the benefits of omega-3 fatty acids.// ... to the aftertaste/burp-back associated with fish oil. , ,Researchers ... fish oil capsule that makes taking omega-3s both easy and ... formulation with a soft chewable shell that can be taken ...
... wide range of medications available , one must also be ... According to the Drug Control Department, 63 batches of spurious ... sold in Bangalore. ,Most of the drugs were ... in some no medicine at all. Karnataka's biggest spurious ...
... help in the brain development of foetus and infants for ... administered to pregnant women. A new study conducted by scientists ... slow down the cognitive decline in middle-aged subjects. , ... and women) with increased levels of homocysteine. This amino acid ...
... investigated the efficacy of acupuncture compared with minimal acupuncture ... the knee.,Acupuncture is a commonly used procedure to treat ... ,By random allocation, patients with chronic osteoarthritis of ... consisting of 150 were allocated to the acupuncture group, ...
... the geriatric population from falling and hurting themselves from being ... Yaktrax Walker. This is plastic netting like structure that conforms ... maintaining a stable walk that will prevent falls. ... a diary of the number of falls they have on ...
... may lose their limb to amputation if there are ... report that areas of the country where there are ... patients of peripheral arterial disease have suffered through an ... diagnosed till late, as often the only symptom experienced ...
Cached Medicine News:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: